ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment

NCT00436852 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

NETWORK

Sponsor class

Conditions

Disseminated Neuroblastoma
Recurrent Neuroblastoma

Interventions

DRUG: ABT-751
PROCEDURE: quality-of-life assessment

Sponsor

Children's Oncology Group

Collaborators

[object Object]